Liu Zongyi: Rocky road ahead for New Delhi’s vaccine export campaign

After a year of novel coronavirus onslaught, the world has entered 2021 with quite a few vaccines available. India, with confirmed COVID-19 cases exceeding 10 million now, is seen rushing into approving two vaccines for emergency usage, including one home-grown candidate which has yet to complete the phase III trials.

Liu Zongyi: Pro-US strategy may push India into the abyss

In a farewell address at the end of his tenure in New Delhi on Tuesday, US Ambassador Kenneth Juster said that the US has cooperated with India to counter "aggressive" Chinese actions at the Line of Actual Control. This is the first time an official confirmed US-India cooperation over the ongoing eight-month-long border standoff between China and India, according to The Hindu on Tuesday.

Trump unleashes final ‘frenzy’ to hamstring Biden

William Jones: Trump's last ditch on Georgia ballot count does no good to U.S. system

In what has been a very surreal U.S. election campaign, the end of voting did not put an end to the controversies. Many Republicans, not just President Donald Trump, believe that Trump was robbed of victory in the November elections.

Zhao Minghao:How will Biden confront Trump's foreign policy legacy?

President-elect Joe Biden will take office in two weeks. The incoming administration, with a strategic objective to "lead the world again," is determined to restore the U.S. global leadership and disperse the clout of Trumpism. However, embarking on that journey isn't easy. Restrained by Trump's foreign policy legacy, Biden is facing political and structural roadblocks.

Prashad and Chomsky: There are 3 major threats to life on Earth that we must address in 2021

Large parts of the world—outside of China and a few other countries—face a runaway virus, which has not been stopped because of criminal incompetence by governments. That these governments in wealthy countries cynically set aside the basic scientific protocols released by the World Health Organization and by scientific organizations reveals their malicious practice. Anything less than focused attention to managing the virus by testing, contact tracing, and isolation—and if this does not suffice, then imposing a temporary lockdown—is foolhardy. It is equally distressing that these richer countries have pursued a policy of "vaccine nationalism" by stockpiling vaccine candidates rather than a policy for the creation of a "people's vaccine." For the sake of humanity, it would be prudent to suspend intellectual property rules and develop a procedure to create universal vaccines for all people.